-transparent.png){kind=logo}
Rabbit antiserum was prepared against purified bovine mild lipoprotein lipase. Immunoelectrophoresis of lipoprotein lipase gave a single precipitin line against the antibody which was coincident with enzyme activity. The gamma-globulin fraction inhibited heparin-releasable lipoprotein lipase activity of bovine arterial intima, heart muscle and adipose tissue. The antibody also inhibited the lipoprotein lipase activity from adipose tissue of human and pig, but not that of rat and dog. Fab fragments were prepared by papain digestion of the gamma-globulin fraction. Fab fragments inhibited the lipoprotein lipase-catalyzed hydrolysis of dimyristoylphosphatidylcholine vesicles and trioleoylglycerol emulsions to the same extent. The Fab fragments also inhibited the lipolysis of human plasma very low density lipoproteins. The change of the kinetic parameters for the lipoprotein lipase-catalyzed hydrolysis of trioleoylglycerol by the Fab fragments was accompanied with a 3-fold increase in Km and a 10-fold decrease in Vmax. Preincubation of lipoprotein lipase with apolipoprotein C-II, the activator protein for lipoprotein lipase, did not prevent inhibition of enzyme activity by the Fab fragments. However, preincubation with dipalmitoylphosphatidylcholine-emulsified trioleoylglycerol or Triton X-100-emulsified trioleoylglycerol had a protective effect (remaining activity 7.0 or 25.8%, respectively, compared to 1.0 or 0.4% with no preincubation). The addition of both apolipoprotein C-II and substrate prior to the incubation with the Fab fragments was associated with an increased protective effect against inhibition of enzyme activity; remaining activity with dipalmitoylphosphatidylcholine-emulsified trioleoylglycerol was 40.6% and with Triton X-100-emulsified trioleoylglycerol, 45.4%. Human plasma very low density lipoproteins also protected against the inhibition of enzyme activity by the Fab fragments. These immunological studies suggest that the interaction of lipoprotein lipase with apolipoprotein C-II in the presence of lipids is associated with a conformational change in the structure of the enzyme such that the Fab fragments are less inhibitory. The consequence of a conformational change in lipoprotein lipase may be to facilitate the formation of an enzyme-triacylglycerol complex so as to enhance the rate of the lipoprotein lipase-catalyzed turnover of substrate to products.
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
October 1972,
The Journal of biological chemistry,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
October 1989,
The Journal of biological chemistry,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
January 1987,
Comparative biochemistry and physiology. B, Comparative biochemistry,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
December 1976,
Biochimica et biophysica acta,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
January 1978,
Biochemical Society transactions,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
April 1986,
Journal of dairy science,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
January 1991,
Methods in enzymology,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
September 1987,
Journal of dairy science,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
August 1962,
Klinische Wochenschrift,
K Shirai, and
D A Wisner, and
J D Johnson, and
L S Srivastava, and
R L Jackson
April 1975,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
